ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD13 Antibody [B-F10] - BSA and Azide free (A341952)

Mouse monoclonal [B-F10] IVD antibody to CD13 for Flow Cytometry.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-CD13 Antibody [B-F10] - BSA and Azide free
Description
Mouse monoclonal [B-F10] IVD antibody to CD13.
Specificity
This product recognizesaminopeptidase N, a 150-170 kDa protein.
Applications
Flow Cytometry
Reactivity
Human
Immunogen
KG-1.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-F10
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c spleen cells
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
Alanyl aminopeptidase, Aminopeptidase M, Aminopeptidase N, ANPEP, AP-M, AP-N, APN, gp150, hAPN, Microsomal aminopeptidase, Myeloid plasma membrane glycoprotein CD13, PEPN
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD13 Antibody [B-F10] - BSA and Azide free (A341952)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD13 Antibody [B-F10] - BSA and Azide free (A341952)

Proteins predicted to interact with CD13

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.6% Relevancy Score
96.5% Relevancy Score
96.4% Relevancy Score
96% Relevancy Score
95.3% Relevancy Score
95.3% Relevancy Score
95.1% Relevancy Score
94.9% Relevancy Score
94.6% Relevancy Score